About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA). For additional information, please see the “About Access to Information Requests” webpage.
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 47 record(s)
Req # A-2023-00069
Policy interpretations related to payments and payment service providers issued since the most recent definition for electronic funds transfers (EFTs) was published in April 2022.Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2024
Req # A-2024-54596
Submission of the Public Health Agency of Canada (PHAC) to the Patented Medicine Prices Review Board’s November 2023 consultation on the Scoping paper of the Board's Guidelines. Submissions from other stakeholders can be viewed here: https://www.canada.ca/en/patented-medicine-prices-review/services/consultations/scoping-paper-board-guidelines.htmlOrganization: Patented Medicine Prices Review Board Canada
February 2024
Nothing to report this month
Organization: Canada Science and Technology Museum
Req # A-2021-00082
All the official correspondences/letters emails on everything pertaining to the application/administration of the Proceeds of Crime (Money Laundering) and Terrorist Financing Act, including the attached documents, sent or received by Sarah Paquet as Director and Chief Executive Officer (CEO) of FINTRAC for the period between July 1, 2021, and November 14, 2021, for the following category: Communication about casinos and dirty moneyOrganization: Financial Transactions and Reports Analysis Centre of Canada
February 2023
Req # A-2022-00022
Strategic intelligence records: Financial Intelligence Reports, Financial Intelligence Briefs and Environmental Scans completed between January 1, 2015, to December 31, 2015, that assess money laundering activities in Canada.Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2023
Req # A-2022-00024
Strategic intelligence records: Financial Intelligence Reports, Financial Intelligence Briefs and Environmental Scans completed between January 1, 2018, to December 31, 2018, that assess money laundering activities in Canada.Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2023
Req # A-2022-00090
Unpublished FINTRAC reports and briefings in respect to potentially laxer rules (i.e. exceptions to businesses/reporting entity requirements under the PCMLTFA) given the COVID-19 crisis and the related challenges to detecting money laundering (date range Feb. 2022-2023)Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2023
Req # A-2022-00094
Strategic intelligence reports/memos that assess money laundering during the convoy occupations last February and since then, including reports on tracking/seizures done connected to the convoy/convoy supporters . (date range: 2021-2023)Organization: Financial Transactions and Reports Analysis Centre of Canada
February 2023
Req # A-2023-02395
Copies of all correspondence and communications between the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier and Innovative Medicines Canada (IMC) between October 1, 2022 and December 5, 2022 regarding the PMPRB's new draft guidelines and the consultation process. Please include all responses to Innovative Medicines Canada (IMC)'s communications/correspondence from the (then) acting chairperson of the Patented Medicines Prices Review Board Mélanie Bourassa-Forcier.Organization: Patented Medicine Prices Review Board Canada
February 2023
Req # A-2022-09063
Copies of any emails sent by the Vice-chair regarding any of the following topics: (i) her resignation or intent to resign or the reasons for her resignation. (ii) the draft guidelines. (iii) the consultation process for the draft guidelines. (iv) the impact of the Merck Canada, IMC, and/or Alexion court decisions on the PMPRB, including its draft guidelines. From November 1, 2022 to December 5, 2022.Organization: Patented Medicine Prices Review Board Canada
February 2023